Article
Amylyx's ALS drug would not be cost effective if priced around $170,000- ICER
Rating:
0.0
Views:
43
Likes:
1
Library:
1
Amylyx Pharmaceuticals Inc's experimental drug for neurodegenerative disease amyotrophic lateral sclerosis (ALS) would not be cost effective if priced around $170,000, an independent U.S. pricing watchdog said on Tuesday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value